 SOUTH SAN FRANCISCO, Calif., Jan. 29, 2021 PRNewswire -- Rigel Pharmaceuticals, Inc. Nasdaq: RIGL today announced it has been awarded 16.5 million by the U.S. Department of Defenses DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense... 